Details
Stereochemistry | RACEMIC |
Molecular Formula | C25H29N3O3.ClH |
Molecular Weight | 455.977 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC(C)(CCN1C(=O)NC2=CC=CC=C12)NCC(O)COC3=CC=CC4=CC=CC=C34
InChI
InChIKey=WXUATBZTSZGPQT-UHFFFAOYSA-N
InChI=1S/C25H29N3O3.ClH/c1-25(2,14-15-28-22-12-6-5-11-21(22)27-24(28)30)26-16-19(29)17-31-23-13-7-9-18-8-3-4-10-20(18)23;/h3-13,19,26,29H,14-17H2,1-2H3,(H,27,30);1H
Molecular Formula | C25H29N3O3 |
Molecular Weight | 419.5161 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Adimolol is an antihypertensive agent with a potent antagonist of central beta-adrenoceptors and has a weaker alpha 1-adrenolytic action. The central alpha 2-antagonistic effect is either very weak or absent. The reduction in beta-adrenoceptor number following adimolol suggests that this prolonged effect may not be solely due to competitive antagonism but may additionally depend upon non-competitive antagonism at beta-adrenoceptors. Adimolol reduced supine, standing and exercise heart rates in a dose dependent manner.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2859871
Single dose - 25, 200, 400 or 800 mg
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:16:51 GMT 2023
by
admin
on
Sat Dec 16 14:16:51 GMT 2023
|
Record UNII |
D9QT537UWA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID00997123
Created by
admin on Sat Dec 16 14:16:51 GMT 2023 , Edited by admin on Sat Dec 16 14:16:51 GMT 2023
|
PRIMARY | |||
|
75708-29-1
Created by
admin on Sat Dec 16 14:16:51 GMT 2023 , Edited by admin on Sat Dec 16 14:16:51 GMT 2023
|
PRIMARY | |||
|
D9QT537UWA
Created by
admin on Sat Dec 16 14:16:51 GMT 2023 , Edited by admin on Sat Dec 16 14:16:51 GMT 2023
|
PRIMARY | |||
|
10049692
Created by
admin on Sat Dec 16 14:16:51 GMT 2023 , Edited by admin on Sat Dec 16 14:16:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |